Profiles

Keywords
Last Name
Institution

Amir Jaffer

Concepts (198)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anticoagulants
32
2019
151
6.890
Why?
Perioperative Care
19
2017
75
4.890
Why?
Venous Thromboembolism
13
2019
53
3.970
Why?
Warfarin
17
2019
60
2.980
Why?
Thromboembolism
14
2015
37
2.910
Why?
Heparin, Low-Molecular-Weight
15
2015
24
2.400
Why?
Surgical Procedures, Operative
7
2017
40
1.890
Why?
Venous Thrombosis
9
2017
51
1.520
Why?
Atrial Fibrillation
9
2016
197
1.450
Why?
Postoperative Complications
14
2015
1083
1.350
Why?
Hospital Medicine
2
2017
2
1.180
Why?
Quality of Health Care
3
2017
141
1.080
Why?
Hospitalists
2
2017
7
0.990
Why?
Polysaccharides
7
2009
20
0.970
Why?
Risk Factors
24
2017
2664
0.930
Why?
Hemorrhage
10
2019
90
0.930
Why?
Risk Assessment
16
2016
806
0.920
Why?
Elective Surgical Procedures
6
2017
55
0.850
Why?
Humans
58
2022
31481
0.810
Why?
Cardiac Surgical Procedures
3
2009
98
0.790
Why?
Platelet Aggregation Inhibitors
4
2013
62
0.640
Why?
Heparin
5
2008
37
0.640
Why?
Gastrointestinal Hemorrhage
2
2015
29
0.630
Why?
Cooperative Behavior
1
2017
86
0.620
Why?
Arthroplasty, Replacement, Hip
6
2019
840
0.620
Why?
Hematologic Diseases
1
2016
17
0.620
Why?
Arthroplasty, Replacement, Knee
6
2019
668
0.580
Why?
Preoperative Care
4
2009
146
0.570
Why?
Quality Improvement
2
2016
173
0.570
Why?
Fibrinolytic Agents
5
2016
99
0.540
Why?
Withholding Treatment
2
2015
10
0.530
Why?
Postoperative Hemorrhage
2
2012
31
0.510
Why?
Postoperative Care
3
2009
141
0.510
Why?
Hospitalization
4
2010
359
0.510
Why?
Blood Coagulation Disorders
2
2016
15
0.500
Why?
Adrenergic beta-Antagonists
2
2014
45
0.490
Why?
Intraoperative Care
2
2009
58
0.450
Why?
Practice Guidelines as Topic
3
2015
389
0.440
Why?
Female
22
2019
18253
0.400
Why?
Patient Care Team
2
2014
153
0.400
Why?
Evidence-Based Medicine
4
2013
239
0.380
Why?
Aged
17
2019
10295
0.380
Why?
United States
6
2017
2539
0.340
Why?
Thrombosis
3
2013
67
0.340
Why?
Patient Readmission
3
2017
129
0.340
Why?
Myocardial Ischemia
1
2008
63
0.340
Why?
Physician's Role
1
2007
22
0.320
Why?
Time Factors
7
2016
1902
0.310
Why?
Hip Fractures
1
2006
30
0.310
Why?
Male
15
2019
17583
0.310
Why?
Administration, Oral
3
2016
164
0.300
Why?
Antithrombins
1
2005
6
0.290
Why?
Stroke
3
2016
367
0.290
Why?
Drug Administration Schedule
5
2014
257
0.280
Why?
Heart Failure
1
2008
232
0.270
Why?
Incidence
4
2015
829
0.270
Why?
Vena Cava Filters
3
2009
10
0.270
Why?
Hirudins
2
2014
2
0.260
Why?
International Normalized Ratio
2
2019
32
0.240
Why?
Aspirin
5
2012
90
0.230
Why?
Anti-Infective Agents
1
2022
59
0.230
Why?
Enoxaparin
3
2012
9
0.210
Why?
Societies, Medical
2
2013
209
0.210
Why?
Aged, 80 and over
7
2014
5234
0.190
Why?
Predictive Value of Tests
3
2016
637
0.190
Why?
American Heart Association
2
2009
39
0.190
Why?
Vitamin K
3
2012
11
0.190
Why?
Odds Ratio
5
2016
327
0.180
Why?
Length of Stay
2
2013
377
0.180
Why?
Intracranial Embolism and Thrombosis
1
1997
3
0.170
Why?
Puerperal Disorders
1
1997
9
0.170
Why?
Treatment Outcome
7
2016
3910
0.170
Why?
Ambulatory Care Facilities
1
2017
42
0.170
Why?
Retrospective Studies
7
2022
3591
0.170
Why?
Heart Valve Prosthesis
3
2012
44
0.160
Why?
Lung Diseases
2
2014
54
0.160
Why?
Follow-Up Studies
3
2019
2028
0.160
Why?
Joint Commission on Accreditation of Healthcare Organizations
1
2016
7
0.160
Why?
Electrocardiography, Ambulatory
1
2016
18
0.160
Why?
Telemetry
1
2016
15
0.160
Why?
Genotype
1
2017
423
0.150
Why?
Primary Health Care
1
2017
106
0.150
Why?
Prognosis
3
2011
1028
0.150
Why?
Heart Rate
1
2016
161
0.140
Why?
Patient Selection
4
2016
264
0.140
Why?
Middle Aged
8
2017
11209
0.140
Why?
Cardiovascular Diseases
3
2014
410
0.140
Why?
Comorbidity
2
2008
562
0.130
Why?
Renal Insufficiency, Chronic
2
2014
103
0.130
Why?
Pulmonary Embolism
1
2014
57
0.130
Why?
Severity of Illness Index
3
2012
1240
0.130
Why?
Pulmonary Surgical Procedures
1
2013
2
0.130
Why?
Cardiovascular Surgical Procedures
1
2013
6
0.130
Why?
Pyridines
2
2016
50
0.130
Why?
Chile
1
2013
1
0.130
Why?
Neoplasms
2
2008
280
0.130
Why?
Kidney Diseases
1
2014
146
0.120
Why?
Ambulatory Surgical Procedures
1
2013
81
0.120
Why?
Risk Reduction Behavior
3
2008
59
0.120
Why?
Adult
7
2017
9779
0.120
Why?
Stents
2
2012
155
0.110
Why?
Magnetic Resonance Imaging
1
1997
1273
0.110
Why?
Disease Management
2
2015
147
0.110
Why?
Myocardial Infarction
1
2011
187
0.100
Why?
Drug Synergism
1
2009
67
0.100
Why?
Premedication
2
2006
6
0.100
Why?
Medication Therapy Management
1
2008
6
0.090
Why?
Prodrugs
1
2008
5
0.090
Why?
Azetidines
1
2008
4
0.090
Why?
Benzylamines
1
2008
15
0.090
Why?
Ohio
1
2008
10
0.090
Why?
Benzimidazoles
1
2008
15
0.090
Why?
Age Factors
2
2014
943
0.090
Why?
Kaplan-Meier Estimate
2
2019
230
0.090
Why?
Stroke Volume
1
2008
64
0.090
Why?
Drug Monitoring
1
2007
29
0.090
Why?
Cause of Death
1
2008
78
0.090
Why?
Thrombolytic Therapy
1
2008
85
0.080
Why?
Colorado
1
2007
5
0.080
Why?
Evaluation Studies as Topic
1
2007
60
0.080
Why?
Echocardiography
1
2008
197
0.080
Why?
Cardiac Catheterization
1
2008
110
0.080
Why?
Chemoprevention
1
2006
7
0.080
Why?
Delirium
1
2006
41
0.080
Why?
Survival Rate
1
2008
465
0.080
Why?
Bariatric Surgery
1
2006
43
0.080
Why?
Lung
1
2006
171
0.070
Why?
Primary Prevention
1
2006
53
0.070
Why?
Intraoperative Complications
1
2006
76
0.070
Why?
Probability
1
2005
104
0.070
Why?
Survival Analysis
1
2006
379
0.070
Why?
Secondary Prevention
1
2005
67
0.070
Why?
Disease Progression
1
2008
861
0.070
Why?
Postmenopause
1
2004
66
0.070
Why?
Orthopedic Procedures
1
2008
322
0.070
Why?
Prospective Studies
1
2010
1934
0.070
Why?
Geriatric Assessment
1
2006
232
0.070
Why?
Hormone Replacement Therapy
1
2004
46
0.070
Why?
Endoscopy, Gastrointestinal
1
2003
12
0.070
Why?
Clinical Trials as Topic
2
2005
378
0.070
Why?
Decision Making
1
2006
232
0.070
Why?
Clinical Protocols
1
2003
75
0.060
Why?
Recombinant Proteins
2
2014
295
0.060
Why?
Randomized Controlled Trials as Topic
2
2016
375
0.060
Why?
Antibodies, Neutralizing
1
2022
26
0.060
Why?
Outpatients
1
2022
56
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2022
136
0.050
Why?
Hospitals
1
2022
142
0.050
Why?
Injections, Subcutaneous
2
2012
41
0.050
Why?
Antibodies, Monoclonal
1
2022
301
0.050
Why?
Anti-Bacterial Agents
1
2022
412
0.050
Why?
Proportional Hazards Models
1
2019
390
0.040
Why?
Adolescent
2
2012
2667
0.040
Why?
Appointments and Schedules
1
2017
15
0.040
Why?
Jugular Veins
1
1997
6
0.040
Why?
Drug Interactions
1
2017
70
0.040
Why?
Cranial Sinuses
1
1997
9
0.040
Why?
Magnetic Resonance Angiography
1
1997
51
0.040
Why?
Medicaid
1
2017
43
0.040
Why?
Pyridones
1
2016
19
0.040
Why?
Thiazoles
1
2016
38
0.040
Why?
Medicare
1
2017
113
0.040
Why?
Regression Analysis
1
2017
319
0.040
Why?
Signal Processing, Computer-Assisted
1
2016
44
0.040
Why?
Focus Groups
1
2016
93
0.040
Why?
Pyrazoles
1
2016
55
0.040
Why?
Double-Blind Method
2
2015
559
0.040
Why?
Perioperative Period
1
2015
13
0.040
Why?
Consensus
1
2016
106
0.040
Why?
Global Health
1
2015
60
0.040
Why?
Clonidine
1
2014
31
0.030
Why?
Delivery of Health Care
1
2016
130
0.030
Why?
Smoking Cessation
1
2014
53
0.030
Why?
Pulmonary Disease, Chronic Obstructive
1
2014
42
0.030
Why?
Heart Arrest
1
2014
48
0.030
Why?
Acute Kidney Injury
1
2014
64
0.030
Why?
Cross-Sectional Studies
1
2017
986
0.030
Why?
Sleep Apnea, Obstructive
1
2014
72
0.030
Why?
Postoperative Period
1
2014
295
0.030
Why?
Multicenter Studies as Topic
1
2012
73
0.030
Why?
Case-Control Studies
2
2004
687
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2014
230
0.030
Why?
Angioplasty, Balloon, Coronary
1
2012
52
0.030
Why?
Hypertension, Pulmonary
1
2011
26
0.030
Why?
Logistic Models
1
2012
479
0.030
Why?
Ticlopidine
1
2008
14
0.020
Why?
Butanones
1
1987
1
0.020
Why?
Dose-Response Relationship, Drug
1
2008
512
0.020
Why?
Health Personnel
1
2008
108
0.020
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
1987
111
0.020
Why?
Young Adult
1
2012
2277
0.020
Why?
Drug Evaluation
1
2004
58
0.020
Why?
Time
1
2004
22
0.020
Why?
Acute Disease
1
2004
254
0.020
Why?
Multivariate Analysis
1
2004
390
0.020
Why?
Osteoarthritis
1
1987
369
0.020
Why?
Patient Dropouts
1
1987
31
0.010
Why?
Random Allocation
1
1987
164
0.010
Why?
Jaffer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description